Bavtavirine

N/A

Report date: 2024/08/16 10:24:27

NME

Base Information

Drug NameBavtavirine

Drug Alias NameHIV NNRTI (GS-5894)GS-5894

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitors

TargetsHuman immunodeficiency virus type 1 reverse transcriptase

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesThailandDominican Republic

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesGilead Sciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHIV Infections

Inactive IndicationsN/A

ATC CodeN/A